Tech Company Financing Transactions

Proprius Pharmaceuticals Funding Round

Proprius Pharmaceuticals, based in San Diego, secured $11 million from Atlas Venture, CDIB Bioscience and Forward Ventures.

Transaction Overview

Company Name
Proprius Pharmaceuticals
Announced On
1/8/2007
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors

Atlas Venture (Lead Investor) (Jean-François Formela)

CDIB Bioscience (Lead Investor)

Forward Ventures (Lead Investor) (Stuart Collinson)

Fog City Fund (Nancy Olson)

Windamere Venture Partners (Scott Glenn)

Proceeds Purpose
This round of financing allows us to complete our Phase II trial of Indaflex, file our Investigational New Drug application with the US Food and Drug Administration, and advance Indaflex towards pivotal Phase III trials later this year.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12264 El Camino Real 300
San Diego, CA 92130
USA
Phone
858-436-1816
Website
www.propriuspharma.com
Email Address
Not Recorded
Overview
Proprius Pharmaceuticals is a specialty pharma company which develops personalized medicine solutions in rheumatology and autoimmune diseases.
Profile
Proprius Pharmaceuticals LinkedIn Company Profile
Social Media
Proprius Pharmaceuticals Company Twitter Account
Company News
Proprius Pharmaceuticals News
Facebook
Proprius Pharmaceuticals on Facebook
YouTube
Proprius Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Walsh
  Michael Walsh LinkedIn Profile  Michael Walsh Twitter Account  Michael Walsh News  Michael Walsh on Facebook
Chief Scientific Officer
DAvid Anderson
  DAvid Anderson LinkedIn Profile  DAvid Anderson Twitter Account  DAvid Anderson News  DAvid Anderson on Facebook
VP - Bus. Development
Douglas Richards
  Douglas Richards LinkedIn Profile  Douglas Richards Twitter Account  Douglas Richards News  Douglas Richards on Facebook
VP - Marketing
Patricia Swartwood
  Patricia Swartwood LinkedIn Profile  Patricia Swartwood Twitter Account  Patricia Swartwood News  Patricia Swartwood on Facebook
VP - R & D
Thierry Dervieux
  Thierry Dervieux LinkedIn Profile  Thierry Dervieux Twitter Account  Thierry Dervieux News  Thierry Dervieux on Facebook
VP - Regulatory Affairs
Marilyn Carlson
  Marilyn Carlson LinkedIn Profile  Marilyn Carlson Twitter Account  Marilyn Carlson News  Marilyn Carlson on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/8/2007: Altos Design Automation venture capital transaction
Next: 1/8/2007: Fluidigm venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.